Some patients involved in trials for lecanemab even saw cognitive scores improve
Copy link
Alzheimer’s wonder drug delays disease for four years
Some patients involved in trials for lecanemab even saw cognitive scores improve
798 words~4 min read
Related reading
Alzheimer’s ‘wonder drug’ slows progression of disease by four years
Patients in the earliest stage of the disease saw little to no decline over four years
New drug could halt Alzheimer’s
Trials suggest ‘game-changing’ treatment could be the most powerful weapon yet against dementia
Alzheimer’s reversed in mice under breakthrough treatment
Injection of nanoparticles “reminds” blood-brain barrier to work properly, allowing brain cells to communicate again
Earlier treatment with amyloid-targeting therapy linked to better outcomes in…
CHICAGO — Patients with Alzheimer’s disease on amyloid-targeting therapy had less cognitive decline when their baseline amyloid…
Erste Patienten bekommen Alzheimer-Mittel Lecanemab - WELT
Das neue Alzheimer-Medikament Lecanemab kann den Verlauf der Krankheit im Frühstadium um einige Monate verzögern. Seit dem 1.…
Erste Patienten bekommen Alzheimer-Mittel Lecanemab
Das neue Alzheimer-Medikament Lecanemab kann den Verlauf der Krankheit im Frühstadium um einige Monate verzögern. Seit dem 1.…